| Edição |
Seção |
Título |
Arquivo |
| Nº 20 (2010) |
Articles |
BRAIN AS TARGET ORGAN IN ARTERIAL HYPERTENSION |
|
| Nº 8 (2011) |
Articles |
SELECTION OF COMBINATION OF AN ACE INHIBITORS AND DIURETICS IN THE TREATMENT OF HYPERTENSION IN THE NEW VERSION OF RUSSIAN RECOMMENDATIONS: FOCUS ON THE TREATMENT OF ELDERLY PATIENTS |
|
| Volume 28, Nº 12 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors |
|
| Volume 28, Nº 13 (2021) |
Articles |
Drug-alcohol interactions: focus on central-acting drugs and analgesics |
|
| Volume 28, Nº 13 (2021) |
Articles |
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs |
|
| Volume 28, Nº 13 (2021) |
Articles |
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure |
|
| Volume 29, Nº 1 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions |
|
| Volume 29, Nº 3 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence |
|
| Volume 29, Nº 11/12 (2022) |
Articles |
Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 2 |
|
| Volume 29, Nº 13 (2022) |
Articles |
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins |
|
| Volume 29, Nº 13 (2022) |
Articles |
Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study |
|
| Volume 30, Nº 14 (2023) |
Cardiology |
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy |
|
| Volume 31, Nº 1 (2024) |
Cardiology |
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease |
|
| Volume 31, Nº 1 (2024) |
Cardiology |
Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management |
|
| Volume 31, Nº 1 (2024) |
Cardiology |
State of cognitive functions in patients with various forms of atrial fibrillation |
|
| Volume 31, Nº 4 (2024) |
Cardiology |
Pharmacotherapy of elderly multimorbid patients with atrial fibrillation in real clinical practice: practical application of STOPP/START criteria |
|
| Volume 31, Nº 4 (2024) |
Cardiology |
Cognitive status of patients with coronary artery disease and concomitant atrial fibrillation |
|
| Volume 31, Nº 4 (2024) |
Cardiology |
Non-alcoholic fatty liver disease as a trigger of polymorbidity. Is there a way out of the impasse? |
|
| Volume 32, Nº 1 (2025) |
Cardiology |
The diagnostic value of determining fibrosis biomarkers in patients with atrial fibrillation and coronary artery disease |
|
| Volume 32, Nº 1 (2025) |
Cardiology |
Known and little-known facts about acetylsalicylic acid |
|
| Volume 32, Nº 1 (2025) |
Gastroenterology/hepatology |
Nonalcoholic fatty liver disease combined with dyslipidemia: the role of ursodeoxycholic acid in complex therapy |
|
